Keita Mori

Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC

Kyoichi Kaira, Tetsuya Higuchi, Ichiro Naruse et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 191 citations

Medicine, Nuclear Medicine, Oncology +15

Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer

Madoka Kimura, Tateaki Naito, Hirotsugu Kenmotsu et al. · Supportive Care in Cancer · 2014 · 179 citations

Medicine, Oncology, Metastasis +14

Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System

Masahito Hosokawa, Hirotsugu Kenmotsu, Yasuhiro Koh et al. · PLoS ONE · 2013 · 178 citations · Full text

Medicine, Biomedical Engineering, Oncology +13

Conventional versus traction-assisted endoscopic submucosal dissection for gastric neoplasms: a multicenter, randomized controlled trial (with video)

Masao Yoshida, Kohei Takizawa, Sho Suzuki et al. · Gastrointestinal Endoscopy · 2017 · 169 citations

Medicine, Oncology, Surgery +12

Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non‐small‐cell lung cancer

Tateaki Naito, Shuichi Mitsunaga, Satoru Miura et al. · Journal of Cachexia Sarcopenia and Muscle · 2018 · 162 citations · Full text

Medicine, Nutrition, Oncology +17